Dr Lal Pathlabs informs about schedule of analyst meet
04 Sep 2019
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting.
The above information is a part of company’s filings submitted to BSE.
Related Dr. Lal Pathlabs Ltd. Links:
1502.70
21.85 (1.48%)
Nov 13, 18:51
1 Year Price Chart
Peers
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 1389.80 |
| Aster DM Healthcare | 145.95 |
| Narayana Hrudayalay | 301.60 |
| Dr Lal Pathlabs | 1502.70 |
| Indraprastha Medical | 41.70 |
| View more.. | |
Sensex vs Dr Lal Pathlabs
